A presentation by Myka Labs CEO Dan Laser will be one of a handful of company presentations that will be spotlighted during the upcoming 2023 BIO Investor Forum, BIO and the company announced today.
The BIO Investor Forum, taking place in San Francisco on October 16-18, is a leading forum for accelerating the progress of new therapeutic technologies into commercialization and treating patients. The Myka Labs presentation, to be made by CEO Dan Laser, will be in a special spotlight session taking place on the first day of the event.
Myka Labs is a clinical-stage company dedicated to helping patients battling challenging conditions like pancreatic cancer live longer, healthier lives. Leveraging artificial intelligence in combination with intraluminal ultrasound and proprietary catheter architectures, ConfluxTM interventional systems from Myka Labs are transformative for high-clinical-impact procedures like bypasses, resections and ablations.